- Ph.D., Pharmaceutical Outcomes & Policy, University of Kentucky
- Pharm.D., University of Arkansas for Medical Sciences
- M.S. Pharmaceutical Evaluation and Policy, University of Arkansas for Medical Sciences
- B.S., Biochemistry, University of Arkansas
Joshua Brown, Pharm.D., Ph.D., M.S., joined the department of pharmaceutical outcomes and policy as an assistant professor in 2016. He received his Doctor of Pharmacy and Master of Science degrees at the University of Arkansas for Medical Sciences in Little Rock, Arkansas, before pursuing a Ph.D. in pharmaceutical outcomes and policy at the University of Kentucky College of Pharmacy. During his doctoral training, Brown worked as the UK-Humana-Pfizer Research Fellow in a unique partnership between academic, managed care and pharmaceutical stakeholders. In his doctoral dissertation, he studied the utilization of vena cava filters for prevention of pulmonary embolism, focusing on the high utilization and low quality of care surrounding these devices, as well as the implementation of interventions to increase that quality of care. He has received funding from the PhRMA Foundation and the Food and Drug Administration to conduct a study on the comparative effectiveness and safety of oral anticoagulants. In 2017, Brown was named a Claude D. Pepper Junior Scholar and will conduct research in geriatric pharmacoepidemiology by linking existing clinical trial data to administrative claims. Brown has also received funding from the Hematology/Oncology Pharmacists Association to investigate treatment patterns and effectiveness in cancer-associated venous thromboembolism. Brown was also named a TEDMED Research Scholar in 2017 and has received a Young Investigator Award from the International Society for Thrombosis and Haemostasis in both 2016 and 2017.
- International Society for Pharmacoeconomics and Outcomes Research
- International Society for Pharmacoepidemiology
- International Society for Thrombosis and Haemostasis
- Health outcomes
- Drug policy
- Quality of care in hematology, cardiology and oncology
- Brown JD, Harnett J, Chambers R, Sato R. The relative burden of community-acquired pneumonia hospitalizations in older adults: an observational cohort study in the United States. BMC Geriatrics. 2018. 18:92. doi:10.1186/s12877-018-0787-2
- Brown JD and Nolte JN. Expanded buprenorphine prescribing privileges: Sandbagging in the midst of the flood? Research in Social and Administrative Pharmacy. 2018 (In press). doi:10.1016/j.sapharm.2018.03.001
- Goodin AJ, Chen M, Raissi D, Han Q, Xiao H, Brown JD. Patient and Hospital Characteristics Predictive of Inferior Vena Cava Filter Usage in Venous Thromboembolism Patients: A Study from the 2013-2014 Nationwide Readmissions Database. Medicine. 2018. 97:12(e0149). doi:10.1097/MD.0000000000010149.
- Chen M, Goodin AJ, Raissi D, Han Q, Xiao H, Brown JD. Hospital-level Variation in Vena Cava Filter Utilization for Patients with Venous Thromboembolism: Implications for quality of care. Vascular Medicine. 2018 (In press).
- Goodin AJ, Raissi D, Han Q, Brown JD. A Review of Institutional Interventions to Increase Vena Cava Filter Retrieval Rates. Annals of Vascular Surgery. 2018 (In press).
- Brown JD, Talbert JC, Pennington R, Han Q, Raissi D. Non-retrieval of inferior vena cava filters as a patient safety concern: evaluation of a new process improvement project to increase retrieval rates in a vascular and interventional radiology clinic. Patient Safety in Surgery. 2018. 12:5. doi:10.1186/s13037-018-0151-7.
- Brown JD, Goodin AJ, Lip GYP, Adams VR. Risk stratification for bleeding complications in patients with venous thromboembolism: Application of the HAS-BLED bleeding score during the first six months of anticoagulant treatment. Journal of the American Heart Association. 2018 (In press). doi:10.1161/JAHA.117.007901
- Brown JD, Raissi D, Han Q, Adams V, Talbert JC. Commentary: Vena Cava Filter Retrieval Rates and Factors Associated with Retrieval in a Large U.S. Cohort. Journal of Vascular Surgery-Venous and Lymphatic Disorders. 2018. Jan;6(1):135-136. doi:10.1016/j.jvsv.2017.10.009
- Goodin AJ, Delcher PC, Valenzuela C, Wang X, Zhu Y, Roussos-Ross D, Brown JD. The power and Pitfalls of Big Data Research in Obstetrics & Gynecology: A Consumer’s Guide. Obstetrics & Gynecology Survey. 2017 Nov;72(11):669-682. doi:10.1097/OGX.0000000000000504.
- Brown JD. Is midazolam a constitutional or pharmacological alternative in lethal injections? Research in Social and Administrative Pharmacy. 2017 Sep 5. pii: S1551-7411(17)30701-5. doi: 10.1016/j.sapharm.2017.08.007.
- El-Refai SM, Black EP, Adams VR, Talbert JC, Brown JD. Statin use and venous thromboembolism in cancer: a large, active comparator, propensity score matched cohort study. Thrombosis Research. 2017 Oct;158:49-58. doi: 10.1016/j.thromres.2017.08.001. Epub 2017 Aug 10.
- Brown JD, Sheer R, Pasquale M, Sudharshan L, Axelsen K, Subedi P, Wiederkehr D, Brownfield F, Kamal-Bahl S. Payer and Pharmaceutical Manufacturer Considerations for Outcomes-Based Agreements in the United States. Value in Health. 2017 Jan;21(1):33-40. doi:10.1016/j.jval.2017.07.009. *Editors’ Choice
- Brown JD, Raissi D, Han Q, Adams VR, Talbert JC. Vena cava filter retrieval rates and factors associated with retrieval in a large United States cohort. Journal of the American Heart Association. 2017 (In press). https://doi.org/10.1161/JAHA.117.006708
- Triplett K, Goodin AJ, Delcher PC, Brown JD, Roussos-Ross K. Opioid drug exposures and health care utilization measures associated with Neonatal Abstinence Syndrome in Florida 2011-2015. Journal of Gynecology & Obstetrics. 2017;1:018.
- Brown JD, Goodin AJ, Talbert JC. Rural and Appalachian Disparities in Neonatal Abstinence Syndrome Incidence and Access to Opioid Abuse Treatment. Journal of Rural Health. 2017 Jul 7. doi: 10.1111/jrh.12251.
Research Gate: https://www.researchgate.net/profile/Joshua_Brown17
Google Scholar: https://scholar.google.com/citations?hl=en&user=HFUbl4YAAAAJ